Innate Pharma Stock Quote IPH - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

2.18

Bid

2.18

Ask

2.245

Volume

19,133

2.18 Day's Range 2.245

2.11 52 Week Range 3.345

Market Cap

176.276M

Previous Close

2.235

Open

2.235

Last Trade

200

2.18

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

66,164

Shares Outstanding

80,860,563

Dividend Yield

PE Ratio

-23.29

Earnings Per Share (EPS)

-0.09

Revenue

61.64M

Net Profit

-7.57M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.innate-pharma.com

Headquarters

Marseille, Bouches-du-rhone, Fra

Founded

1970

Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IPH. The last closing price for Innate Pharma was 2.24 €. Over the last year, Innate Pharma shares have traded in a share price range of 2.11 € to 3.345 €.

Innate Pharma currently has 80,860,563 shares outstanding. The market capitalization of Innate Pharma is 176.28 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -23.29.

Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) will hold its Annual General Meeting of Shareholders (“AGM”) at 10:30 a.m. CEST on May 23, 2024...

Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate

IPH45 is a novel and differentiated exatecan-Antibody Drug Conjugate targeting Nectin-4 In PDX models of urothelial tumors, IPH45 has stronger activity than approved Nectin-4 targeting EV. IPH45...

Innate Pharma Announces Its Participation in Upcoming Investor Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team are scheduled to participate in the upcoming...

Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2023 Universal Registration Document (Document d’enregistrement...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.03	1.39534883721	2.15	2.265	2.11	61695	2.18895671	DE
4	0.005	0.229885057471	2.175	2.385	2.11	69397	2.2337349	DE
12	-0.32	-12.8	2.5	2.5	2.11	66164	2.26069773	DE
26	-0.29	-11.7408906883	2.47	2.8	2.11	94205	2.38585548	DE
52	-0.52	-19.2592592593	2.7	3.345	2.11	91647	2.55178072	DE
156	-1.32	-37.7142857143	3.5	5.735	1.986	211438	3.41833473	DE
260	-3.69	-62.8620102215	5.87	7.5	1.986	268060	4.18390107	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NCPLNetcapital Inc	$ 0.165 (26.24%)	774.96k
GGLLDirexion Daily GOOGL Bull 2X ETF	$ 44.30 (23.02%)	21.92k
WORXSCWorx Corporation	$ 3.10 (12.73%)	117.22k
GOOGLAlphabet Inc	$ 173.94 (11.49%)	1.51M
MSFUDirexion Daily MSFT Bull 2X ETF	$ 45.44 (11.40%)	35.32k
VINCVincerx Inc	$ 0.74 (-16.71%)	24.74k
ISUNiSun Inc	$ 0.146 (-15.61%)	966.33k
ELTXElicio Therapeutics Inc	$ 8.00 (-11.85%)	200
GGLSDirexion Daily GOOGL	$ 13.62 (-11.44%)	21.77k
DXCMDexCom Inc	$ 123.40 (-10.66%)	33.97k
SQQQProShares UltraPro Short QQQ	$ 11.59 (-3.38%)	1.67M
GOOGLAlphabet Inc	$ 173.94 (11.49%)	1.51M
INTCIntel Corporation	$ 33.11 (-5.78%)	1.32M
TLTiShares 20 plus Year Treasury Bond	$ 87.82 (0.07%)	1.11M
MSFTMicrosoft Corporation	$ 421.269 (5.45%)	1.05M